CTKB Cytek Biosciences: Earnings growth forecast for next year
Cytek Biosciences, Inc. (CTKB) is creating a closed ecosystem of spectral cytometers, ensuring stable revenue through multi-year supplies of consumables. This chart, generated by the GURU.Markets system, serves as a benchmark for the consensus EPS forecast for the coming year, where the value of 35.50 represents the current metric. Prospects are based on unique patents in cellular analysis and compliance with environmental waste disposal regulations.
Metric breakdowns and analytics for cytekbio.com (CTKB)
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- company liabilities and liquidity data:
Total Debt to Capital Cytek Biosciences, Inc.|CTKB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Cytek Biosciences|CTKB - Company Aggregate Debts|Debt to Book Value Cytek Biosciences|CTKB - Company Long-Term Loans and Borrowings|Company Short-Term Debts Cytek Biosciences|Quick Ratio cytekbio.com
- earnings and market ratios statistics:
CTKB - Net Financial Result|Expected Profit Cytek Biosciences, Inc.|CTKB - Market Cap to Earnings|Future Price to Earnings Cytek Biosciences, Inc.|CTKB - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Cytek Biosciences|CTKB - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Cytek Biosciences|CTKB - Net earnings per share for the last four quarters|Quarterly EPS earnings growth cytekbio.com|CTKB - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Cytek Biosciences, Inc.
Basic company analysis:Cytek Bio
Cytek Biosciences, Inc. (CTKB) leverages an efficient network of external suppliers to scale production, which is directly reflected in the projected EPS dynamics for the coming year. This metric aggregates expert forecasts on profit growth rates, capturing market expectations prior to earnings releases, thereby helping investors timely identify the risk of asset overvaluation or a forthcoming deterioration in business parameters.
Competitor analysis for Cytek Biosciences, Inc.
Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ILMN|Expected earnings per share growth for next year exactsciences.com EXAS|Revvity - Expected earnings per share growth for next year|Bio-Rad Laboratories, Inc. (BIO) - Expected net earnings per share growth next year|NNNN: Expected earnings per share growth for next year|Nordion - Projected earnings per share increase next year|QDEL: Earnings growth forecast for next year|Expected net earnings per share growth next year opko.com (OPK)|Net earnings per share growth forecast for next year CareDx, Inc.|Earnings growth forecast for next year Maravai LifeSciences Holdings|Expected earnings per share growth for next year FLGT (Fulgent Corp)|LAB (Standard BioTools Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year OSUR (OraSure Technologies)|Exagen Inc - Net earnings per share growth forecast for next year|MDxHealth - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Lucid Diagnostics, Inc. LUCD|prenetics.com (PRE) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Insight Molecular Diagnostics Inc (IMDX)|Net earnings per share growth forecast for next year Trinity Biotech PLC|prophaselabs.com (PRPH) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year AIMD|Expected earnings per share growth for next year Co-Diagnostics Inc CODX|Earnings growth forecast for next year HSCS (Heart Test Laboratories Inc.)|Consensus forecast of earnings per share growth for next year Biomerica Inc (BMRA)|Cardio Diagnostics Holdings, Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year onconetix.gcs-web.com|Virax Biolabs (VRAX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year BJDX|AWH (Vermillion) - Earnings growth forecast for next year|Expected earnings per share growth for next year Accelerate Diagnostics Inc (AXDX)|Earnings growth forecast for next year CNTG|ENZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Fresh2 Group FRES|Consensus forecast of earnings per share growth for next year Genetic Technologies Ltd (GENE)|ME: Expected earnings per share growth for next year|Expected earnings per share trend next year PMD (Psychemedics Inc)
